Company profile for Climb Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Climb Bio is a clinical-stage biopharmaceutical company focused on developing differentiated monoclonal antibodies to treat immune-mediated diseases where patient outcomes remain poor. Our pipeline targets large populations with high unmet need using novel therapies such as anti-CD19 and anti-APRIL antibodies in indications like primary membranous nephropathy, immune thrombocytopenia, systemic lupus erythematosus, and IgA ne...
Climb Bio is a clinical-stage biopharmaceutical company focused on developing differentiated monoclonal antibodies to treat immune-mediated diseases where patient outcomes remain poor. Our pipeline targets large populations with high unmet need using novel therapies such as anti-CD19 and anti-APRIL antibodies in indications like primary membranous nephropathy, immune thrombocytopenia, systemic lupus erythematosus, and IgA nephropathy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
20 William Street, Suite 145 • Wellesley Hills, MA 02481
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/01/08/3215211/0/en/Climb-Bio-Announces-Pipeline-Progress-and-Strategic-Priorities-for-2026.html

GLOBENEWSWIRE
08 Jan 2026

https://www.globenewswire.com/news-release/2025/11/25/3194179/0/en/Climb-Bio-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/10/21/3170038/0/en/Climb-Bio-Names-Adam-Villa-as-SVP-Technical-Operations-and-Ashley-Jones-as-SVP-People-Workforce-Strategy.html

GLOBENEWSWIRE
21 Oct 2025

https://www.globenewswire.com/news-release/2025/10/17/3168527/0/en/Climb-Bio-to-Present-Data-at-American-Society-of-Nephrology-ASN-Kidney-Week-2025.html

GLOBENEWSWIRE
17 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty